BridgeMD
New treatment option for Smoking
Official title Self-determination Plus Instant Messaging for Smokers With Cancer
ClinicalTrials.gov ID: NCT05643469
What this study is testing
- What it's testing
- Objective: To test the efficacy of a self-determination theory-based intervention plus instant messaging to help smokers with cancer quit smoking. Hypothesis to be tested: Subjects who are allowed to choose their quit schedule and receive regular instant messaging about smoking cessation will show a significantly higher biochemically validated quit rate than those who receive only brief advice to quit immediately.
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- smoked weekly in the last 6 months,
- diagnosed with any cancer for at least 6 months and at all cancer stages (I, II, III, or IV),
- aged 18 years or above and can communicate in Cantonese, and
- own a smartphone and able to use instant messaging (e.g. WhatsApp or WeChat)
You likely can't join if
- individuals with unstable medical conditions, poor cognitive state, or mental illness as advised by the doctor in charge and noted on their medical...
- those participating in other smoking cessation programmes.
The study team makes the final eligibility decision.
Where it's taking place
- Hong Kong, Hong Kong
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hong Kong, Hong Kong. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.